In this compelling episode of Longevity by Design, Dr. Gil Blander speaks with renowned physician-scientist Dr. Evelyne Bischof about the emerging discipline of longevity medicine. A leader in both clinical and academic arenas, Dr. Bischof shares how this evolving field is shifting healthcare from reactive “sick care” to proactive health optimization—using personalized diagnostics, cutting-edge technology, and AI.

Key Points:

Dr. Evelyne Bischof is helping transform medicine by making personalized, data-driven longevity care mainstream. With diagnostics, AI, and global collaboration, longevity medicine is redefining what it means to age well.

• What Is Longevity Medicine?: Longevity medicine goes beyond prevention to optimize health span—the years we live in good health—by targeting aging itself using personalized diagnostics, biological age tracking, and predictive AI tools.
• Beyond the Annual Check-Up: Unlike traditional primary care, longevity clinics integrate detailed biomarkers, brain scans, genomics, and even wearables data to tailor interventions like supplements, medications, and lifestyle changes specific to each patient’s aging trajectory.
• From ICU to AI: A Physician's Journey: Having spent years in acute care and oncology, Dr. Bischof now focuses on empowering people to avoid age-related disease altogether—merging clinical insight with data science to predict and delay biological decline.
• Global Movement & Future Discipline: Longevity medicine is gaining traction worldwide, with notable leadership from the U.S., China, UAE, and Israel. Dr. Bischof advocates for establishing it as a certified medical discipline supported by flexible, evidence-based standards.
• Inside the Sheba Longevity Center: At Israel’s Sheba Medical Center, Dr. Bischof is leading a pioneering public study that tracks 1,500 people using over 450 biomarkers. It’s one of the first longevity-focused clinical trials embedded in a major hospital.
• Healthy Longevity Medicine Society (HLMS): As president of HLMS, Dr. Bischof works to standardize longevity care, train clinicians, and create global registries. The aim is to build an ecosystem where AI, personalized care, and clinical excellence converge.